(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

----------

AIM - WINNERS

----------

Norman Broadbent PLC, up 23% at 6.45 pence, 12-month range 3.00p-6.84p. The recruitment firm says revenue in the first quarter of 2023 jumped 67% annually to GBP2.9 million from GBP1.8 million. Net fee income rises 66% to GBP2.4 million from GBP1.5 million. Looking ahead, Norman Broadbent notes "excellent forward momentum", with a pipeline of contracted revenue at the end of the quarter of GBP2.6 million. The company expects to publish its results for 2022 later this month.

----------

Oncimmune Holdings PLC, up 9.5% to 40.41p, 12-month range 34.00p-106.09p. The immuno-diagnostics developer says it has sold its wholly-owned subsidiaries, Oncimmune Ltd and Oncimmune Europe GmbH to Freenome Holdings, for GBP13 million in cash. Oncimmune will continue to operate its ImmunoINSIGHTS business, primarily through its subsidiary Oncimmune Germany GmbH. Also says Oncimmune Germany and Freenome have signed a long-term have signed a master services agreement.

----------

AIM - LOSERS

----------

Lansdowne Oil & Gas PLC, down 56% at 0.19p, 12-month range 0.17p-0.64p; and Barryroe Offshore Energy PLC, down 42% at 1.08p, 12-month range 0.90p-4.13p. On Friday, Barryroe said a government minister in Ireland is not "satisfied with the financial capability" of those involved in an oil and gas lease application. The company, chasing a Dublin government green light for the SEL1/11 licence, said it received correspondence from Eamon Ryan, Ireland's minister for the Department of the Environment, Climate & Communications. SEL1/11 houses the Barryroe field. Barryroe Offshore owns an 80% stake in the asset, while Lansdowne Oil & Gas PLC owns 20%. On Monday, Lansdowne says it has received no direct correspondence from the Irish government department regarding the decision. However, it notes that it has verified the content directly with Barryroe. Lansdowne says that it has engaged with external legal counsel to assess its legal rights and the potential options available, including pursuing legal proceedings, for the purposes of protecting its investment in the Barryroe project.

----------

By Sophie Rose, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.